Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain drain removal showdown: quick clamp vs. slow wean

NCT ID NCT07630051

Knowledge-focused Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two strategies for removing an external ventricular drain (a tube that drains fluid from the brain) in 170 adults who had a brain bleed. One method clamps the drain shut as soon as it's safe, while the other gradually raises the drain over time. The goal is to see which approach reduces the number of days the drain stays in, lowering infection risk and hospital stay.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could establish a standard, safer method for removing brain drains after bleeding, potentially reducing infections and hospital stays.
What could go wrong
This is an early-stage trial with no prior proof that one method is better. Results may not apply to all patients, and both methods carry risks like infection or need for a permanent shunt.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 170 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Oct 2031

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patient (≥18 years) * Admitted to critical care for non-traumatic subarachnoid hemorrhage for less than 3 days * First external ventricular drain inserted within the last 3 days for hydrocephalus and/or intracranial hypertension * Patient consent, or consent from a relative, or inclusion under emergency inclusion procedure * Patient affiliated to or beneficiary of a social security scheme Exclusion Criteria: * Moribund patient or patient with established treatment limitation/withdrawal decisions * Patient with a pre-existing ventriculoperitoneal or ventriculoatrial shunt * Patient with chronic hydrocephalus * Pregnant, lactating, or parturient woman * Person deprived of liberty by judicial or administrative decision * Person under involuntary psychiatric care * Person under a legal protection measure * Concurrent participation in another study involving external ventricular drainage management

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for External ventricular drainage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hydrocephalus intracranial hypertension subarachnoid hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

External ventricular drainage Hydrocephalus Intracranial hypertension Subarachnoid hemorrhage

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital Angers

    Angers, France

  • University Hospital Brest

    Brest, France

  • University Hospital Nantes

    Nantes, France

  • University Hospital Poitiers

    Poitiers, France

  • University Hospital Rennes

    Rennes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.